Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-25T09:18:14.463Z Has data issue: false hasContentIssue false
  • English
  • Français

Steroids in acute spinal cord injury

Published online by Cambridge University Press:  21 May 2015

Canadian Association of Emergency Physicians

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
CAEP Position Statement • Déclaration De Position De L’ACMU
Information
Canadian Journal of Emergency Medicine , Volume 5 , Issue 1 , January 2003 , pp. 7 - 9
Copyright
Copyright © Canadian Association of Emergency Physicians 2003

References

1.Bracken, MB, Shepard, MJ, Collins, WF, Holford, TR, Young, W, Baskin, DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322(20):1405–11.Google Scholar
2.Coleman, WP, Benzel, D, Cahill, DW, Ducker, T, Geisler, F, Green, B, et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 2000;13(3):185–99.CrossRefGoogle ScholarPubMed
3.Hurlbert, RJ.Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000;93(1 suppl):1–7.Google ScholarPubMed
4.Hurlbert, RJ.The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine 2001;26(24 suppl):S39–46.CrossRefGoogle ScholarPubMed
5.Nesathurai, S.Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 1998;45(6):1088–93.CrossRefGoogle ScholarPubMed
6.Rosner, MJ.Methylprednisolone for spinal cord injury. J Neurosurg 1992;77(2):324–5; discussion 325–7.Google Scholar
7.Short, DJ, El Masry, WS, Jones, PW.High dose methylprednisolone in the management of acute spinal cord injury – a systematic review from a clinical perspective. Spinal Cord 2000;38 (5):273–86.CrossRefGoogle ScholarPubMed
8.Short, D.Use of steroids for acute spinal cord injury must be reassessed. BMJ 2000;321(7270):1224.Google ScholarPubMed
9.Wilkinson, HA.Spinal cord injury. J Neurosurg 2001;94(1 suppl):180–1.Google ScholarPubMed
10.74 Cal. Rptr. 2d 550, 98 Cal. Daily Op. Serv. 3574, Daily Journal D.A.R. 4851 (Cal. App 2 Dist., May 08, 1998) (no. B088559).Google Scholar
11.Bracken, MB.Pharmacological interventions for acute spinal cord injury. Cochrane Database Syst Rev 2000;(2):CD001046.Google ScholarPubMed
12.Otani, K, Abe, H, Kadoya, S, Nagakawa, H, Ikata, T, Tominagu, S, et al. Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury. Sekitsui Sekizui J 1994;7:633–47.Google Scholar
13.Petitjean, ME, Pointillart, V, Dixmerias, F, Wiart, L, Sztark, F, Lassie, P, et al. Medical treatment of spinal cord injury in the acute stage. Ann Fr Anesth Reanim 1998;17(2):114–22.CrossRefGoogle ScholarPubMed
14.Bracken, MB, Collins, WF, Freeman, DF, Sheppard, MJ, Wagner, FW, Silten, RM, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984;251(1):45–52.CrossRefGoogle ScholarPubMed
15.Bracken, MB, Shepard, MJ, Hellenbrand, KG, Collins, WF, Leo, LS, Freeman, DF, et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. J Neurosurg 1985;63(5):704–13.Google Scholar
16.Bracken, MB, Shepard, MJ, Collins, WF Jr, Holford, TR, Baskin, DS, Eisenberg, HM, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76(1):23–31.Google Scholar
17.Bracken, MB, Shepard, MJ, Holford, TR, Leo-Summers, L, Aldrich, EF, Fazl, M, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277(20):1597–604.Google Scholar
18.Bracken, MB, Shepard, MJ, Holford, TR, Leo-Summers, L, Aldrich, EF, Fazl, M, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998;89(5):699–706.CrossRefGoogle ScholarPubMed
19.Hugenholtz, H, Cass, DE, Dvorak, MF, Fewer, DH, Fox, RJ, Izukawa, DMS, et al. High-dose methylprednisolone for acute closed spinal cord injury: only a treatment option. Can J Neurol Sci 2002;29(3):227–35.CrossRefGoogle ScholarPubMed
20.Ditunno, JF Jr.Predicting recovery after spinal cord injury: a rehabilitation imperative. Arch Phys Med Rehab 1999;80:361–4.Google Scholar
21.Matsumoto, T, Tamaki, T, Kawakami, M, Yoshida, M, Ando, M, Yamada, H.Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine 2001;26(4):426–30.Google Scholar
22.Galandiuk, S, Raque, G, Appel, S, Polk, HC Jr. The two-edged sword of large-dose steroids for spinal cord trauma. Ann Surg 1993;218(4):419–25; discussion 425–7.Google Scholar
23.Shepard, MJ, Bracken, MB.The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study. Paraplegia 1994;32(4):236–45.Google ScholarPubMed
24.Gerndt, SJ, Rodriguez, JL, Pawlik, JW, Taheri, PA, Wahl, WL, Micheals, AJ, et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma 1997;42(2):279–84.CrossRefGoogle ScholarPubMed